Who Exports Voriconazole from India — 144 Suppliers Behind a $31.3M Market
India's voriconazole export market is supplied by 144 active exporters who collectively shipped $31.3M across 1,413 shipments. SANDOZ PRIVATE LIMITED leads with a 27.1% market share, followed by INTIGREAT CONSULTING SERVICES LLP and MSN LABORATORIES PRIVATE LIMITED. The top 5 suppliers together control 63.6% of total export value, reflecting a concentrated market structure.
Top Voriconazole Exporters from India — Ranked by Export Value
SANDOZ PRIVATE LIMITED is the leading voriconazole exporter from India, holding a 27.1% share of the $31.3M market across 1,413 shipments from 144 exporters. The top 5 suppliers — SANDOZ PRIVATE LIMITED, INTIGREAT CONSULTING SERVICES LLP, MSN LABORATORIES PRIVATE LIMITED, AJANTA PHARMA LIMITED, GLAND PHARMA LTD — collectively control 63.6% of total export value, indicating a moderately concentrated market. Individual shares are: SANDOZ PRIVATE LIMITED (27.1%), INTIGREAT CONSULTING SERVICES LLP (17.8%), MSN LABORATORIES PRIVATE LIMITED (7.9%), AJANTA PHARMA LIMITED (5.6%), GLAND PHARMA LTD (5.1%).
Top Voriconazole Exporters from India
Ranked by export value · 144 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SANDOZ PRIVATE LIMITED MATERIAL NO. - 44087965, VORICONAZOLE 20MATERIAL NO- 44087965 VORICONAZOLE 200MG30FCT CNVORICONAZOLE FOR INJECTION 200MG/VIAL, 3 | $8.5M | 8 | 27.1% |
| 2 | INTIGREAT CONSULTING SERVICES LLP VORIFLAN 200 MG. B.: AL5001 M. 03/2025 E.: 02/2027VORIFLA 25 ML. | $5.6M | 1 | 17.8% |
| 3 | MSN LABORATORIES PRIVATE LIMITED VORICONAZOLE 200MG INJ DRL-BRAVORIOLE 200 1X10VORICONAZOLE 200MG INJ 1X1S DRL-BRA | $2.5M | 11 | 7.9% |
| 4 | AJANTA PHARMA LIMITED VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $1.8M | 1 | 5.6% |
| 5 | GLAND PHARMA LTD VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $1.6M | 4 | 5.1% |
| 6 | ASPIRO PHARMA LIMITED VORICONAZOLE 200MG INJ DRL-BRAVORIOLE 200 1X10VORICONAZOLE 200MG INJ 1X1S DRL-BRA | $1.4M | 15 | 4.5% |
| 7 | INTAS PHARMACEUTICALS LIMITED VORICONAZOLE 200MG INJ DRL-BRAVORIOLE 200 1X10VORICONAZOLE FC TABS 200MG 28S 2X14S UK 4195X28S=117460NOS | $1.4M | 14 | 4.5% |
| 8 | MYLAN LABORATORIES LIMITED VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $1.4M | 6 | 4.4% |
| 9 | GLAND PHARMA LIMITED VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $1.3M | 3 | 4.2% |
| 10 | AUROBINDO PHARMA LTD VORICONAZOLE FC TABS 200MG 28S 2X14S UK 4195X28S=117460NOSVORICONAZOLE MYLAN 200 MG 56 BL TAB PACKVORICONAZOLE FC TABS 200 MG 28S | $585.0K | 3 | 1.9% |
| 11 | AUROBINDO PHARMA LIMITED VORICONAZOLE FC TABS 200MG 28S 2X14S UK 4195X28S=117460NOSVORICONAZOLE MYLAN 200 MG 56 BL TAB PACKVORICONAZOLE FC TABS 200 MG 28S | $570.3K | 3 | 1.8% |
| 12 | DR REDDYS LABORATORIES LIMITED MATERIAL NO. - 44087965, VORICONAZOLE 20MATERIAL NO- 44087965 VORICONAZOLE 200MG30FCT CNMATERIAL NO.-44087965, VORICONAZOLE 200M | $524.3K | 2 | 1.7% |
| 13 | UNITED BIOTECH PRIVATE LIMITED | $506.9K | 8 | 1.6% |
| 14 | HIGLANCE LABORATORIES PRIVATE LIMITED VORICOZ VORICONAZOLE TABLETVORICOZ VORICONAZOLETAB 200MVORICOZ VORICONAZOLE TABLETS 200MG. | $475.1K | 1 | 1.5% |
| 15 | ZYDUS LIFESCIENCES LIMITED VORICONAZOLE FOR INJECTION 200MG/VIAL, 3VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIALVORICONAZOLE TABLETS 200 MG 30BT TAB NOS | $443.5K | 1 | 1.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Voriconazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Warning Letter, June 2019 | Yes | Yes | Multiple | Received FDA warning letter in June 2019 for CGMP deviations; holds WHO-GMP and |
| MSN Laboratories Private Limited | Approved | Yes | Yes | Multiple | Holds FDA approvals, WHO-GMP, and EU GMP certifications; no FDA warning letters. |
| Mylan Laboratories Limited | Approved | Yes | Yes | Multiple | Holds FDA approvals, WHO-GMP, and EU GMP certifications; no FDA warning letters. |
| Intas Pharmaceuticals Limited | Approved | Yes | Yes | Multiple | Holds FDA approvals, WHO-GMP, and EU GMP certifications; no FDA warning letters. |
| Dr. Reddy's Laboratories Limited | Approved | Yes | Yes | Multiple | Holds FDA approvals, WHO-GMP, and EU GMP certifications; no FDA warning letters. |
| Zydus Lifesciences Limited | Approved | Yes | Yes | Multiple | Holds FDA approvals, WHO-GMP, and EU GMP certifications; no FDA warning letters. |
| Aspiro Pharma Limited | Approved | Yes | Yes | Multiple | Holds FDA approvals, WHO-GMP, and EU GMP certifications; no FDA warning letters. |
| Ajanta Pharma Limited | Approved | Yes | Yes | Multiple | Holds FDA approvals, WHO-GMP, and EU GMP certifications; no FDA warning letters. |
| Gland Pharma Ltd | Approved | Yes | Yes | Multiple | Holds FDA approvals, WHO-GMP, and EU GMP certifications; no FDA warning letters. |
| Intigreat Consulting Services LLP | Not Listed | No | No | Not Applicable | No regulatory certifications or approvals found. |
TransData Nexus reviewed the regulatory standing of 10 leading Voriconazole exporters from India. 8 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Voriconazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal center for active pharmaceutical ingredient (API) production. The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. The presence of Genome Valley, India's first biotech cluster, underscores Hyderabad's role in pharmaceutical innovation and manufacturing.
The city's robust infrastructure and skilled workforce make it a strategic location for API production, including Voriconazole. Notably, Sidhiv Pharma Pvt Ltd, based in Hyderabad, is a distributor of Voriconazole API, highlighting the city's capacity in this domain.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and is home to companies like Zydus Lifesciences and Cadila Pharmaceuticals.
This region's emphasis on formulations suggests a significant role in producing finished Voriconazole products, leveraging its advanced manufacturing facilities and regulatory compliance.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceuticals. Mumbai, being India's financial hub, hosts numerous pharmaceutical headquarters and facilitates extensive distribution networks.
Companies like Taj Pharmaceuticals Ltd., with manufacturing facilities in Raigad, produce Voriconazole tablets, indicating the region's role in both production and export logistics.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, is recognized as Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units. The region's growth has been bolstered by tax incentives and favorable government policies, attracting numerous pharmaceutical companies.
While Baddi's primary focus has been on large-scale formulation manufacturing, its infrastructure supports the production of various pharmaceutical products, potentially including Voriconazole.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess suppliers' compliance with international quality standards and their capacity to meet demand fluctuations.
- Leverage Regional Strengths: Utilize Hyderabad's API production capabilities and Ahmedabad-Vadodara's formulation expertise to optimize the supply chain.
- Monitor Regulatory Changes: Stay informed about policy shifts, especially in tax incentive zones like Baddi, to anticipate potential impacts on sourcing strategies.
By strategically sourcing from these key pharmaceutical clusters, companies can enhance the reliability and efficiency of their Voriconazole supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Voriconazole exporters from India
Ajanta Pharma Limited — Ajanta Pharma announces ₹285 crore share buyback
On May 2, 2024, Ajanta Pharma Limited announced a buyback of 1,028,881 equity shares, representing 0.82% of its total paid-up equity share capital, at ₹2,770 per share, aggregating to ₹285 crore. - IMPACT: This buyback may influence Ajanta Pharma's financial strategy, potentially affecting its investment in Voriconazole production and export capabilities.
Impact: This buyback may influence Ajanta Pharma's financial strategy, potentially affecting its investment in Voriconazole production and export capabilities.
Common Questions — Voriconazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which voriconazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SANDOZ PRIVATE LIMITED leads with 146 recorded shipments worth $8.5M. INTIGREAT CONSULTING SERVICES LLP (4 shipments) and MSN LABORATORIES PRIVATE LIMITED (100 shipments) are also established high-volume exporters.
Q How many voriconazole manufacturers are there in India?
India has 144 active voriconazole exporters with a combined export market of $31.3M across 1,413 shipments to 114 countries. The top 5 suppliers hold 63.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for voriconazole from India?
Average FOB unit price: $11.41 per unit, ranging from $0.01 to $1001.82. Average shipment value: $22.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 144 verified Indian exporters of Voriconazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,413 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 114 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,413 Verified Shipments
144 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists